tiprankstipranks
Sona Nanotech Inc (TSE:SONA)
:SONA
Canadian Market
SONA
Sona Nanotech Inc
RESEARCH TOOLSreports

Sona Nanotech Inc (SONA) Stock News & Sentiment

54 Followers
Sona Nanotech’s Hyperthermia Platform Boosts Immunotherapy Response in Colorectal Cancer Study
Premium
Company Announcements
Sona Nanotech’s Hyperthermia Platform Boosts Immunotherapy Response in Colorectal Cancer Study
3d ago
Sona Nanotech to Detail Promising Cancer Therapy Data in Investor Webinar
Premium
Company Announcements
Sona Nanotech to Detail Promising Cancer Therapy Data in Investor Webinar
24d ago
Sona Nanotech’s Innovative Approach to Metastatic Melanoma: A Study Update
Premium
Company Announcements
Sona Nanotech’s Innovative Approach to Metastatic Melanoma: A Study Update
6M ago
SONA
Sona Nanotech’s Innovative Approach to Metastatic Melanoma: A Clinical Study Update
Premium
Company Announcements
Sona Nanotech’s Innovative Approach to Metastatic Melanoma: A Clinical Study Update
6M ago
SONA
Sona Nanotech to Host Webinar on Innovative Cancer Therapy Clinical Study
Premium
Company Announcements
Sona Nanotech to Host Webinar on Innovative Cancer Therapy Clinical Study
6M ago
Sona Nanotech Advances Clinical Trial for Innovative Cancer Therapy
Premium
Company Announcements
Sona Nanotech Advances Clinical Trial for Innovative Cancer Therapy
8M ago
Sona Nanotech Receives Ethics Approval for Melanoma Therapy Pilot Study
Premium
Company Announcements
Sona Nanotech Receives Ethics Approval for Melanoma Therapy Pilot Study
9M ago
More TSE:SONA News >

SONA News on the Web

Sona Nanotech’s Hyperthermia Platform Boosts Immunotherapy Response in Colorectal Cancer Study
TipRanks News
Neutral
Sona Nanotech preclinical study shows tumor regression in colorectal cancer model
Proactive Investors
Neutral
Sona Nanotech to Detail Promising Cancer Therapy Data in Investor Webinar
TipRanks News
Neutral
Sona Nanotech CEO on breakthrough cancer therapy results - ICYMI
Proactive Investors
Neutral
Sona Nanotech poised for clinical breakthrough after melanoma study
Proactive Investors
Neutral
Sona Nanotech poised for clinical breakthrough after melanoma study
Proactive Investors
Neutral
Sona Nanotech reveals positive response rate in first-in-human THT cancer therapy study
Proactive Investors
Neutral
Sona Nanotech advances first-in-human cancer therapy trial
Proactive Investors
Neutral

News Score - Last 7 Days

Neutral
TSE:SONA
Sector Average
Media Buzz
This Week3 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TSE:SONA’s Media Buzz Sentiment?
3 articles about TSE:SONA were published this week. In an average week, 1 articles are published.
    What is TSE:SONA’s weekly average amount of articles?
    In an average week, 1 articles about TSE:SONA are published.
      What is TSE:SONA’s News Sentiment?
      50% of articles about TSE:SONA were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        NBIXNeurocrine
        STAAStaar Surgical
        AORTArtivion
        OWLTOwlet
        HUMHumana
        Showing the stocks with the most bullish news sentiment over the past week